Skip to main content
. 2019 Nov 28;2019(11):CD012475. doi: 10.1002/14651858.CD012475.pub2

Cattaneo 2018.

Methods A bi‐centre randomised rater‐blinded controlled trial
Participants People with MS
Interventions Participants in the intervention group received treatment aimed at improving balance and mobility. Participants in the control group received treatments to reduce limitations at activity and body function level
Outcomes Primary measures were frequency of fallers (>1 fall in two months) and responders (>3 points improvement) at the Berg Balance Scale (BBS)
Notes If suitable, we will include this study in the next iteration of this Cochrane review